Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;4(4):233-6.
doi: 10.4103/2229-3485.120173.

Causality assessment: A brief insight into practices in pharmaceutical industry

R Purushotham Naidu  1
Affiliations

Causality assessment: A brief insight into practices in pharmaceutical industry

R Purushotham Naidu. Perspect Clin Res. 2013 Oct.

Abstract

Healthcare industry is flooded with multitude of drugs, and the list is increasing day by day. Consumption of medications has enormously increased due to life style changes, having safer drugs is the need of the hour. Regulators and other authorities to have a check have put in stringent regulations and pharmacovigilance system in place. Eventhough there has been increase in adverse drug reactions (ADR) reporting in the last decade, causality assessment has been the greater challenge for academicians and even industry. Causality is crucial for risk benefit assessment, particularly when it involves post marketing safety signals. Pharmaceutical companies have put in efforts to have a standardized approach for causality assessment. This article will provide some insight into the approaches for causality assessment from a pharma industry perspective.

Keywords: Adverse drug reactions; causality; pharmacovigilance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Meyboom RH, Royer RJ. Causality classification in pharmacovigilance centres in the European community. Pharmacoepidemiol Drug Saf. 1992;1:87–97.
    1. Kramer MS. Assessing causality of adverse drug reactions. Drug Inf J. 1986;20:433–778.
    1. Jones JK. Determining causation from case reports. In: Strom BL, editor. Pharmacoepidemiology. 2nd ed. Chichester, Hoboken, San Fransisco: Wiley & Sons Ltd; 1994. pp. 365–78.
    1. Amery WK. ISPE. Signal generation from spontaneous adverse event reports. Pharmacoepidemiol Drug Saf. 1999;8:147–50. - PubMed
    1. The use of the WHO-UMC system for standardised case causality assessment. [Last accessed on 2012 Dec 10]. Available from: http//www.who-umc.org/Graphics/24734.pdf .